#VisualAbstract: Presence of anti-telomerase CD4+ Th1 immunity is associated with better outcomes in patients with melanoma
Click to read the study in the Journal of Investigative Dermatology.
Tag: immunotherapy
#VisualAbstract: Greater immunosuppression is associated with worse outcomes in patients with advanced melanoma receiving ipilimumab and anti-PD-1 therapy
Click to read the study in the European Journal of Cancer.
#VisualAbstract: Adjuvant pembrolizumab does not reduce health-related quality of life in patients with stage III melanoma
Click to read the study in The Lancet Oncology. Click to see previously reported survival outcomes from the same cohort.
#VisualAbstract: Avelumab does not improve outcomes in patients receiving chemoradiotherapy for squamous cell carcinomas of the head and neck
Click to read the study in The Lancet Oncology.
#VisualAbstract: Pembrolizumab improves long-term survival in patients with stage III melanoma
Click to read the study in The Lancet Oncology.
#VisualAbstract: Nivolumab plus ipilimumab is safe and effective for the treatment of advanced melanoma (CheckMate 218)
Click to read the study in Melanoma Research.
Cemiplimab monotherapy significantly improves outcomes in patients with advanced non-small-cell lung cancer with PD-L1 of at least 50%
1. Median overall survival and progression-free survival were significantly improved with cemiplimab monotherapy compared to chemotherapy. 2. Patients treated with ...
#VisualAbstract: Long-term pembrolizumab monotherapy maintains efficacy despite the occurrence of immune-related adverse events in patients with advanced melanoma
Click to read the study in European Journal of Cancer
Quick Take: T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
Genetically engineered T-cell therapies, such as chimeric antigen receptor T-cells (CAR T-cells), have been approved for the treatment of hematologic ...
De novo design of artificial IL-2 mimic for the treatment of cancer [PreClinical]
1. IL-2 is a central cytokine that enhances the immune response, with considerable potential for the treatment of cancer. 2. ...